While there are many studies focusing on the mechanism underlying the HIF2α-dependent promotion of ccRCC progression, studies regarding the mechanism of how HIF1α inhibits tumors are insufficient. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.